MIFH
ANGO icon

Migdal Insurance & Financial Holdings’s AngioDynamics ANGO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-767
Closed -$12K – 545
2017
Q2 		$12K Buy
+767
New +$12.1K ﹤0.01% 441

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ANGO Position: Q3 2017 in Review

Migdal Insurance & Financial Holdings sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 767 shares — an estimated $12K sold.

Migdal Insurance & Financial Holdings first reported a position in ANGO in Q2 2017 and held it in 1 quarter. The position peaked at $12K in Q2 2017. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • Migdal Insurance & Financial Holdings reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 767 AngioDynamics shares in Q3 2017, an estimated $12K.
  • Migdal Insurance & Financial Holdings first reported a position in AngioDynamics in Q2 2017 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's AngioDynamics position peaked at $12K in Q2 2017.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2017, filed 6 Nov 2017.